Mounjaro Solution for Injection: What It Is and How It Is Supplied in the UK (October 2026)

01 · The core answer

What "Mounjaro solution" actually means in the UK

Mounjaro solution for injection is the liquid form of tirzepatide, supplied in a pre-filled KwikPen. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹ The pen comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

The words "solution for injection" are the regulatory description of the product. They simply mean the medicine is dissolved in liquid and given by injection. They do not mean the liquid is sold separately, in a vial, or in a form you can measure with a syringe. The pen does the measuring for you. You dial the dose, press the button as the leaflet instructs and the pen delivers it.

The pen is a sealed delivery device with a fixed design, and the safe route is always to use it as intended.

02 · What to do next

The decisions most readers are really facing

Most people reading about the solution are weighing up one of three things. The first is whether Mounjaro is relevant to them at all. It is licensed for adults, and your prescriber decides suitability after reviewing your health questionnaire. It is used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹

The second is whether a different liquid product, such as a vitamin-containing combination, could be better. Any liquid combination product is a question for a prescriber rather than something to improvise, and our guide to tirzepatide and cyanocobalamin goes deeper.

The third is practical: how to get the pen, how to store it and how to use it without waste or error. If you are ready to look at supply, the Mounjaro pen with live prices and a free consultation is the place to start. Our consultation is free, the price shown is the price paid, and every order is reviewed by a GPhC-registered prescriber; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. New customers save £40 on their first order with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). If you want the wider picture first, our weight loss clinic page sets out the options.

03 · What tirzepatide is

What is in the solution: tirzepatide

The active ingredient in the solution is tirzepatide. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ The medicine comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Each strength is a different amount of the same medicine. That is why pens are not interchangeable at random: the strength printed on the box and the pen is the strength your prescriber has chosen for that stage of your treatment. Always check the label against your prescribed dose before you inject.

The solution is designed to be kept cold before use and handled gently. It is not something to shake, dilute, split or combine. The solution should be clear and colourless; do not use a pen that looks cloudy or discoloured or has particles in it. If you are unsure about the appearance of the liquid in your pen, do not guess. Contact the pharmacy that supplied it and describe what you see.¹³

How tirzepatide works

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic).¹ The weekly schedule is a feature of how long the medicine stays active in the body.

That long activity is also why stopping is not instant. Tirzepatide takes roughly four to five weeks to clear the system after a final dose. There is no way to speed this up, and nothing needs doing while it clears.¹ For the same reason, a single missed injection is not a crisis, and the missed-dose rules give you a clear path.

For readers comparing this with other liquids and oral forms, our pages on GLP-1 solutions in general and on the oral solution options for weight loss explain how those products are described and why they should not be assumed to behave like a Mounjaro pen. Mounjaro itself is an injection only. Whatever form of medicine you consider, the same principles apply: licensed product, genuine supply, prescriber review and a plan for follow-up.

04 · Pen, not vial

Pen, not vial: why you should not use a syringe

The UK Mounjaro solution is supplied inside a KwikPen, and the pen should be used only as designed. Withdrawing liquid from the pen with a syringe is not how the product is licensed or designed to be used. Withdrawing liquid from the pen creates unknown dosing accuracy, risks contamination and bypasses the safeguards built into the device.

The pen is set by turning the dose knob until the dose indicator shows the correct dose in the window.

Is there liquid left in the pen at the end?

It is common to look at a finished pen and wonder whether a usable amount is left. Each pen is designed and licensed to deliver exactly four weekly doses, so the last bit of liquid is not a spare dose. Do not try to top up a short dose from a new pen, and do not try to scrape out the remainder. Dispose of the finished pen in your sharps bin.

The pen also tells you when it has done its job. Because each pen is built for four weekly doses, a pen on a regular weekly schedule is empty about when your next order is due. If your pen seems to run out earlier or later than expected, contact the pharmacy rather than adjusting your dosing to compensate.

Milligrams versus millilitres

Many people see a strength in milligrams on the box and then look for a volume to measure. With a pen, you do not need a volume. The strength you are prescribed is the dose the pen delivers when the window shows that dose. The conversion from milligrams to a syringe measurement is a feature of vials and compounded products, and it is exactly where dosing errors happen. If someone is offering you tirzepatide in a vial with a conversion chart, treat it as a warning sign: it is not the licensed UK product. Our guide to GLP-1 liquid solutions explains why liquid products of unclear origin carry extra risk.

Splitting or stretching a pen

Splitting a pen into intermediate doses is not licensed, not supported by the pen's design and not endorsed by any UK regulator.¹ Altering doses outside the licence means unknown dosing accuracy and no safety data.

If you are struggling with side effects at your current strength, talk to your prescriber.

05 · Dose ladder

The dose ladder: how strengths are used

Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself.¹ After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.¹

Why each strength is a separate pen

Because the solution is pre-filled at a fixed concentration for each strength, you cannot turn a lower-strength pen into a higher one. Each stage of the ladder needs the matching pen.

If you miss a dose

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other.¹

These rules protect you from accidentally doubling up. They also mean there is no need to panic about a late injection. Check the days, follow the rule and move on.

Changing your injection day

You can change your weekly injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹ People often do this around travel, shift work or holidays. Pick the new day, count the gap from your last injection, and keep to the new day afterwards.

Review points along the way

Treatment is reviewed rather than left on autopilot. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ Our service includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so the pace stays under clinical control.

06 · How to inject

How to inject the solution

Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food.¹ Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Each KwikPen contains four weekly doses.¹

Needles, a sharps bin and injection guidance are included with every order. Read the leaflet's step-by-step instructions before your first injection and keep it to hand. The pen's own instructions govern how long to hold it in place and when it has finished delivering; follow them rather than a time you have read elsewhere.¹³

Is there a best time of day?

There is no "best" time of day. Mounjaro works the same morning or evening, with or without food. What matters is the same day each week. Pick a day and time you will remember, and stick to it. Many people choose a weekend morning so early side effects fall on days off.¹

Setting the dose correctly

The most common worry for new users is whether they have set the pen correctly. The rule is simple: turn the dose knob until the dose indicator shows the correct dose in the window. If the window will not reach a full dose, stop; that pen cannot supply a proper injection.

What the first injections feel like

The starting weeks are about adjustment, and experiences differ widely. Some people notice appetite change and early loss in the first week, while others feel little until a higher dose. Both are normal. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

If a symptom worries you, or you notice something that is not described in the leaflet, speak to your prescriber. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Our broader walkthrough, how to take a GLP-1 solution, covers general technique that applies to pen-based injectables.

What about teeth grinding?

Teeth grinding is not a listed side effect in the UK Mounjaro patient leaflet.¹³ If you notice it after starting treatment, mention it to your prescriber or dentist, and report it through the Yellow Card scheme if you suspect a link.¹⁹

07 · Storage and travel

Storing the pen so the solution stays reliable

Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, useful for short trips, after which it should be discarded. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

The practical points follow from that. Put new pens in the main body of the fridge rather than the door or against the back wall, where items can freeze. Keep the cap on between uses. If a pen has frozen, do not try to thaw and use it; contact the pharmacy for advice.

Unopened pens out of the fridge

Unopened pens should be kept in the fridge and keep until the expiry date printed on the box. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit. Figures circulating online often come from other countries' labels.¹ The UK patient information leaflet is the reference to use.¹³

Our deliveries use free next-day tracked delivery (DPD) in temperature-controlled, discreet packaging. Put your pens in the fridge as soon as they arrive.

Travelling with the solution

You can fly with Mounjaro. Carry pens in hand luggage, because hold luggage can fall below freezing, ideally in a cool bag with the prescription label or a copy of your prescription. In-use pens tolerate up to 30 days not above 30°C, so most holidays need no special arrangements. For hot climates, use an insulated pouch. Check destination rules for travelling with prescription injectables before you fly.¹

Before you go, count your pens against the weeks you will be away, plus a margin for delays, and check your injection day. If your trip crosses your usual day, you can move the injection day as long as there are at least 3 days between doses.¹

Checking the liquid before use

Look at the solution through the pen's window before each injection, and compare it with the description in your patient information leaflet.¹³ If the solution looks cloudy or discoloured, has particles in it, or the pen has been damaged, frozen or above 30°C, do not use it. Faulty, damaged or wrong items should be reported to us within the stated window so we can sort out a replacement or refund. Never inject from a pen you doubt: it is better to wait and ask than to guess.

08 · Realistic results

What the solution can realistically deliver

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² As a worked example only, for someone starting at 100 kg, 20.9% is about 21 kg. Trial averages do not predict your own result.

How much can you lose in three months?

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.¹ In SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12. A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation, and slower early progress does not predict failure.

Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. Some people notice a change in the first week; others notice little until a higher dose.¹ Both patterns are normal.

What shapes your own outcome

Your dose, how well you tolerate it, your eating pattern, your activity level and how consistently you inject all play a part. The medicine reduces appetite and slows stomach emptying, but it works best when you use that breathing space to build habits that last. A reduced-calorie diet and increased physical activity are part of the licensed use, not optional extras.¹

Tracking helps. The free GLPTrackr companion app (iOS and Android) lets you log injections, doses and progress in one place, so you can see the trend rather than reacting to a single day. Bring that record to your monthly review.

If results are slower than expected

Slower progress is not a reason to change your dose yourself. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That review is built into treatment so the decision is made with clinical input, not guesswork or forum advice.

09 · Combination products

Tirzepatide with cyanocobalamin and other add-ins

Cyanocobalamin is a form of vitamin B. The licensed Mounjaro product is tirzepatide in the KwikPen.¹ We supply genuine Mounjaro KwikPens through official LillyDirect supply, and we do not offer a pre-mixed tirzepatide and vitamin liquid in place of it.

If a seller advertises a combined vial or a pen refill with extra ingredients, ask who made it, under which licence, and whether it needs a prescription. Our related guides, on tirzepatide and cyanocobalamin and on cyanocobalamin injections for weight loss, explain how the vitamin is described and why it should not be treated as a weight-loss medicine in its own right. Any decision about adding a vitamin is one for a prescriber or your GP, based on your own health.

Spotting unsafe supply

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected problems.⁷ Warning signs of an unsafe seller include offering to supply without a consultation or prescription, selling "research" vials, promising specific results, supplying a liquid with a conversion chart in place of a pen, and prices that bear no relation to the rest of the market. A genuine UK supplier will be listed on the GPhC register. Ours is registered as GPhC 9012878, and you can check it on the GPhC register.

Interactions to raise with your prescriber

Tell your prescriber about every medicine you take. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Tirzepatide slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar.

Reporting problems

Tell your prescriber about any new or lasting symptom. For severe, persistent stomach pain, get medical help straight away. You can also report it via the Yellow Card scheme, which helps regulators monitor safety.¹⁹ Our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · NHS and private

NHS or private: how people get the solution

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you think you may qualify for NHS treatment, ask your GP. If you prefer not to wait, you can buy Mounjaro privately from a registered pharmacy. Either way, treatment is a clinical decision and should involve a prescriber review.

Can I buy Mounjaro privately?

Yes, if a prescriber judges it suitable for you. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹ It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

With us, the process has four steps:

• Complete a free online consultation, a short health questionnaire with no charge and no obligation.
• A GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Our registered pharmacy dispenses your pen, with same-day dispatch when ordered by 3pm.
• Free next-day tracked delivery arrives in temperature-controlled, discreet packaging. Saturday delivery is £14.99.

Planning the cost

Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and all six doses are in stock. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, before discounts. A new customer's first order is £40 less, and every later order is £25 less (code DOSE25). We accept Visa and Mastercard, Klarna and pay-monthly options, with no subscriptions.

For the pen itself, see our KwikPen product guide or go straight to the Mounjaro pen page. Prices checked 11 October 2026.